PREVENTION

Hypertension Chapter Readings

1. Healthy People 2010.  Leading Health Indicators

2. JNC 7.  Complete Report

3. An Economic Evaluation of the JNC Hypertension Guidelines Using Data from a Randomized Controlled Trial

4. Primary Prevention of Hypertension: Clinical and Public Health Advisory from the National High Blood Pressure Education Program

5. Screening for Hypertension

6. Facts About the DASH Eating Plan

7. DASH (Dietary Approaches to Stop Hypertension) diet is effective treatment for stage 1 isolated systolic hypertension

8. Effect of Dietary Sodium Intake on Blood Lipids: results from the DASH-sodium trial

9. Effects of Comprehensive Lifestyle Modification on Blood Pressure Control.  Main Results of the PREMIER Clinical Trial

10. Losartin Intervention for Endpoint Reduction in Hypertension Study (LIFE)

11. Trials in isolated systolic hypertension: an update

12. Antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT)

13. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

14. Irbesartan MicroAlbiminuria Type 2 Diabetes in Hypertensive Patients Study (IRMA II)

15. Reduction of Endpoints in NIDDM With the Angiotensin II Antagonist Losartin Study (RENAAL)

16. The Irbesartan in Diabetes Nephropathy Trial (IDNT)

17. The Hypertension Detection and Follow-Up Program (HDFP)

18. Five-year findings of the hypertension detection and follow-up program.  I.  Reduction in mortality of persons with high blood pressure, including mild hypertension.  Hypertension Detection and Follow-Up Program Cooperative Group.

19. The African American Study of Kidney Disease and Hypertension (AASK)

20. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial

21. The Heart Outcomes Prevention Evaluation Study (HOPE)

22. The Hypertension Optimal Treatment Study (HOT)

23. Risk Factors for Progression of Renal Disease

24. Brief description of the multiple risk factor intervention trial